These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 28639131)
1. miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature. Fittipaldi S; Vasuri F; Bonora S; Degiovanni A; Santandrea G; Cucchetti A; Gramantieri L; Bolondi L; D'Errico A Dig Dis Sci; 2017 Sep; 62(9):2397-2407. PubMed ID: 28639131 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related]
3. Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers. Vasuri F; Fittipaldi S; Giunchi F; Monica M; Ravaioli M; Degiovanni A; Bonora S; Golfieri R; Bolondi L; Grigioni WF; Pasquinelli G; D'Errico-Grigioni A J Clin Pathol; 2016 Feb; 69(2):102-8. PubMed ID: 26243063 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293 [TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713 [TBL] [Abstract][Full Text] [Related]
7. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
8. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
9. Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis. Wong CM; Wong CC; Lee JM; Fan DN; Au SL; Ng IO Hepatology; 2012 May; 55(5):1453-61. PubMed ID: 22135159 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma. Lendvai G; Szekerczés T; Gyöngyösi B; Schlachter K; Kontsek E; Pesti A; Patonai A; Werling K; Kovalszky I; Schaff Z; Kiss A Pathol Oncol Res; 2019 Jul; 25(3):1103-1109. PubMed ID: 30411298 [TBL] [Abstract][Full Text] [Related]
11. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma. Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665 [TBL] [Abstract][Full Text] [Related]
12. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
13. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma. Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538 [TBL] [Abstract][Full Text] [Related]
14. A Large Set of miRNAs Is Dysregulated from the Earliest Steps of Human Hepatocellular Carcinoma Development. Sulas P; Di Tommaso L; Novello C; Rizzo F; Rinaldi A; Weisz A; Columbano A; Roncalli M Am J Pathol; 2018 Mar; 188(3):785-794. PubMed ID: 29248455 [TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma. Wojcicka A; Swierniak M; Kornasiewicz O; Gierlikowski W; Maciag M; Kolanowska M; Kotlarek M; Gornicka B; Koperski L; Niewinski G; Krawczyk M; Jazdzewski K Int J Biochem Cell Biol; 2014 Aug; 53():208-17. PubMed ID: 24875649 [TBL] [Abstract][Full Text] [Related]
16. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC. Salvi A; Abeni E; Portolani N; Barlati S; De Petro G Int J Oncol; 2013 Feb; 42(2):391-402. PubMed ID: 23229173 [TBL] [Abstract][Full Text] [Related]
17. Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p. Wang Y; Sun B; Sun H; Zhao X; Wang X; Zhao N; Zhang Y; Li Y; Gu Q; Liu F; Shao B; An J Tumour Biol; 2016 Aug; 37(8):10965-79. PubMed ID: 26891666 [TBL] [Abstract][Full Text] [Related]
18. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection. Zekri AN; El-Sisi ER; Youssef ASE; Kamel MM; Nassar A; Ahmed OS; El Kassas M; Barakat AB; Abd El-Motaleb AI; Bahnassy AA PLoS One; 2018; 13(3):e0193709. PubMed ID: 29534065 [TBL] [Abstract][Full Text] [Related]
20. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]